Home

SEC Filings

SEC Filing Keyword Search (View search tips)
Groupings Filter (View SEC Groupings descriptions)
View Section 16 Filings (3,4,5)
<< First | Previous | Next | Last >>
Filing DateFormDescriptionFiling GroupDownloads
02/14/11SC 13GA statement of beneficial ownership of common stock by certain personsOther Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/14/11SC 13GA statement of beneficial ownership of common stock by certain personsOther Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/14/11SC 13G/AAn amendment to the SC 13G filingOther Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/14/11SC 13GA statement of beneficial ownership of common stock by certain personsOther Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/11/11SC 13GA statement of beneficial ownership of common stock by certain personsOther Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/10/11SC 13GA statement of beneficial ownership of common stock by certain personsOther Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/10/114Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
02/10/114Statement of changes in beneficial ownership of securities3,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
12/09/108-K/AAmendment to a previously filed 8-KCurrent Reports Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
11/02/1010-QQuarterly report which provides a continuing view of a company's financial positionQuarterly Filings Download SEC Filing to Word Download SEC Filing to Excel Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
<< First | Previous | Next | Last >>
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.60
Change (%) Stock is Down 0.12 (16.67%)
Volume2,000
Data as of 05/17/13 12:55 p.m. ET
Minimum 20 minute delay
Refresh quote
What's New
May 15, 2013
Tengion Provides Business Update and Reports First Quarter 2013 Financial Results
-- Phase 1 trial of Neo-Kidney Augment™ on track for initiation in Sweden in second quarter of 2013 and in U.S. in fourth quarter of 2013 -- -- Actively recruiting for final three patients in Neo-Urinary Conduit™ trial -- WINSTON-SALEM, N.C., May 15, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today provided a business update and reported its financial results for the first quarter ended March 31, 2013. "We are very pleased to have achieved a sig... 
April 01, 2013
Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
WINSTON-SALEM, N.C., April 1, 2013 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today announced the acceptance of the Company's Clinical Trial Application (CTA) filed with the Medical Products Agency (MPA) in Sweden to initiate a Phase 1 clinical trial to evaluate the safety and delivery of its Neo-Kidney Augment™ product in up to five patients with advanced chronic kidney disease (CKD).  "We are excited to have received MPA approval for the Neo-Kidney Augm...